June 2026
1. MOURA-FERREIRA S, Pugliese NR, Verwerft J
   Response by Moura-Ferreira et al Regarding Article, "Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation".
   Circulation. 2026;153:e1392-e1393.
   

   >> Share

   
   
2. BADANO LP, Tomaselli M, Caravita S
   Letter by Badano et al Regarding Article, "Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation".
   Circulation. 2026;153:e1390-e1391.
   

   >> Share

   
   May 2026
3. FERREIRA ZIMMER C, Marquard JM, Jabbari R, Sabbah M, et al
   Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial.
   Circulation. 2026;153:1687-1690.
   

   >> Share

   
   
4. MEHAFFEY JH, Miller DC, Kaul S, Badhwar V, et al
   Current Incidence and Modality of Young Aortic Valve Replacement in the United States.
   Circulation. 2026;153:1520-1522.
   

   >> Share

   
   
5. DHONT S, Moura Ferreira S, Galloo X, Martens P, et al
   Angiotensin Receptor Neprilysin Inhibitor in Heart Failure with Preserved Ejection Fraction and Secondary Mitral Regurgitation: the PRAISE-MR Randomized Trial.
   Circulation. 2026 May 9. doi: 10.1161/CIRCULATIONAHA.126.080833.
   

   >> Share

   
   April 2026
6. ROSE D
   Letter by Rose Regarding Article, "Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis".
   Circulation. 2026;153:e1151-e1152.
   

   >> Share

   
   
7. KANG DH
   Response by Kang to Letter Regarding Article, "Long-Term Outcomes of Early Surgery versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis".
   Circulation. 2026;153:e1153.
   

   >> Share

   
   
8. PRZYBYLSKI R, Norrish G, Claggett B, Ashley EA, et al
   The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
   Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.126.078843.
   

   >> Share

   
   
9. VISSING CR, Axelsson Raja A, Helms AS, Saberi S, et al
   Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
   Circulation. 2026;153:1104-1116.
   

   >> Share

   
   March 2026
10. LIN B, Wang J, Li C, Wang S, et al
    CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy.
    Circulation. 2026;153:845-862.
    

    >> Share

    
    
11. KAR S
    Response by Kar to Letter Regarding Article, "Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial".
    Circulation. 2026;153:e937.
    

    >> Share

    
    
12. SUN P
    Letter by Sun Regarding Article, "Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial".
    Circulation. 2026;153:e936.
    

    >> Share

    
    
13. ZHANG X, Hao Y, Han D, Jin X, et al
    PRMT3-Mediated Arginine Methylation Stabilizes PCSK9 to Promote Aortic Valve Calcification.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078830.
    

    >> Share

    
    February 2026
14. THERIAULT S, Holdcraft JA, Sharipova D, Faucherre A, et al
    Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074752.
    

    >> Share

    
    
15. ARNOLD SV, Spertus JA, Gosch K, Dunlay SM, et al
    Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study.
    Circulation. 2026;153:310-318.
    

    >> Share

    
    January 2026
16. BATTISTOLO Q, Avvedimento M, Guerin P, Turgeon PY, et al
    Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review.
    Circulation. 2026;153:115-131.
    

    >> Share

    
    
17. PARK SJ, Kim M, Son J, Jo HH, et al
    Correction to: Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.
    Circulation. 2026;153:e12.
    

    >> Share

    
    
18. TANGUTURI VK, Elmariah S
    Response by Tanguturi and Elmariah to Letter Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
    Circulation. 2026;153:e2-e3.
    

    >> Share

    
    
19. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
    Circulation. 2026;153:e1.
    

    >> Share

    
    December 2025
20. XU A, Weissman D, Ermer KJ, Bertero E, et al
    Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.
    Circulation. 2025;152:1705-1727.
    

    >> Share

    
    
21. GIRI J, Nathan AS
    Transcatheter Aortic Valve Replacement With Local Anesthesia: When Less Is Less?
    Circulation. 2025;152:1538-1540.
    

    >> Share

    
    November 2025
22. MARGONATO D, Enriquez-Sarano M, Nishihara T, Phichaphop A, et al
    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance.
    Circulation. 2025 Nov 12. doi: 10.1161/CIRCULATIONAHA.125.074862.
    

    >> Share

    
    
23. MOURA-FERREIRA S, Pugliese NR, Milani M, Taddei S, et al
    Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation.
    Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.073778.
    

    >> Share

    
    October 2025
24. ADAMS DH, Pandis D
    Expert Hands, Favorable Curves: Parsing the Evidence for Early Mitral Valve Repair.
    Circulation. 2025;152:1218-1220.
    

    >> Share

    
    
25. SCHWANN TA, Habib RH, Saadat S, Abbas AE, et al
    Surgery for Periprocedural Failure of Transcatheter Aortic Valve Replacement in the United States.
    Circulation. 2025;152:1262-1264.
    

    >> Share

    
    
26. GARCIA HERNANDEZ S, de la Higuera Romero L, Fernandez A, Luisa Pena Pena M, et al
    Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.
    Circulation. 2025;152:1060-1075.
    

    >> Share

    
    
27. CAMPAIN J, Griskowitz C, Newlands C, Claggett BL, et al
    Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.
    Circulation. 2025;152:990-1002.
    

    >> Share

    
    September 2025
28. AYUBA G, Bhatt A, Bavry A
    Percutaneous Solutions for Tricuspid Regurgitation: Current Approved Options and Identifying Ideal Candidates.
    Circulation. 2025;152:909-912.
    

    >> Share

    
    
29. KRISHNASWAMY A, Reed GW
    Defining Optimal Treatment Strategies for Bicuspid Aortic Valve Stenosis With Balloon- and Self-Expandable Transcatheter Heart Valves.
    Circulation. 2025;152:658-660.
    

    >> Share

    
    
30. WAGNILD JM, Bayliss C, Maier RH, Ogundimu E, et al
    Accelerometer-Measured Physical Activity After Mitral Valve Surgery: An Analysis of the UK Mini Mitral Randomized Controlled Trial.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.074651.
    

    >> Share

    
    August 2025
31. MESSIKA-ZEITOUN D, Chu MWA, Bouchard D, Le Tourneau T, et al
    Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry.
    Circulation. 2025 Aug 31. doi: 10.1161/CIRCULATIONAHA.124.073674.
    

    >> Share

    
    
32. KENNEDY J, Blackman DJ, Dodd M, Poggesi A, et al
    Impact of Cerebral Embolic Protection On Cognitive Function Following Transcatheter Aortic Valve Implantation: Data From the BHF PROTECT-TAVI Randomized Trial.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076761.
    

    >> Share

    
    
33. JORGENSEN TH, Savontaus M, Willemen Y, Bleie O, et al
    Three-Year-Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients with Tricuspid or Bicuspid Aortic Stenosis.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076678.
    

    >> Share

    
    
34. FEISTRITZER HJ, Ender J, Lauten P, Rudolph TK, et al
    Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
    Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076557.
    

    >> Share

    
    
35. GIACOPPO D, Alvarez-Covarrubias H, Xhepa E, Matsuda Y, et al
    Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.
    Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.124.069323.
    

    >> Share

    
    
36. PARK SJ, Kim M, Son J, Jo HH, et al
    Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.
    Circulation. 2025 Aug 13. doi: 10.1161/CIRCULATIONAHA.125.074560.
    

    >> Share

    
    June 2025
37. GENEREUX P, Lindman BR, Pibarot P
    New Classification to Describe Clinical Presentation in Aortic Stenosis: Stable, Progressive, and Acute Valve Syndrome.
    Circulation. 2025;151:1627-1629.
    

    >> Share

    
    
38. BERRY JD, de Lemos JA
    Biomarkers to Guide the Timing of Aortic Valve Replacement in Asymptomatic Aortic Stenosis: Where Do We Stand After Early TAVR?
    Circulation. 2025;151:1565-1567.
    

    >> Share

    
    May 2025
39. PRABHU NK, Aykut B, Mensah-Mamfo M, Overbey DM, et al
    Partial Heart Transplantation: Early Experience With Pediatric Heart Valve Replacements That Grow.
    Circulation. 2025;151:1477-1490.
    

    >> Share

    
    
40. DESAI MY, Wolski K, Owens A, Geske JB, et al
    Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.
    Circulation. 2025;151:1378-1390.
    

    >> Share

    
    
41. METRA M, Tomasoni D, Adamo M, Anker SD, et al
    Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions.
    Circulation. 2025;151:1342-1363.
    

    >> Share

    
    April 2025
42. VEKSTEIN AM, Wegermann ZK, Manandhar P, Mack MJ, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry.
    Circulation. 2025 Apr 3. doi: 10.1161/CIRCULATIONAHA.124.071838.
    

    >> Share

    
    March 2025
43. LINDMAN BR, Pibarot P, Schwartz A, Oldemeyer JB, et al
    Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial.
    Circulation. 2025 Mar 31. doi: 10.1161/CIRCULATIONAHA.125.074425.
    

    >> Share

    
    
44. TANGUTURI VK, Abou-Karam R, Cheng F, Duan R, et al
    Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: a Randomized Clinical Trial.
    Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074470.
    

    >> Share

    
    
45. KAR S, Makkar RR, Whisenant BK, Hamid N, et al
    Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.
    Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074536.
    

    >> Share

    
    
46. MEISNER JK, Renberg A, Smith ED, Tsan YC, et al
    Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.
    Circulation. 2025;151:783-798.
    

    >> Share

    
    February 2025
47. ROSA M, Dupont A, Smadja DM, Soquet J, et al
    Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug Repositioning.
    Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.124.071954.
    

    >> Share

    
    
48. ZHANG B, Enriquez-Sarano M, Schaff HV, Michelena HI, et al
    Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy.
    Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.123.066523.
    

    >> Share

    
    January 2025
49. PARK SJ, Kang DH
    Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e28.
    

    >> Share

    
    
50. WANG J, Peng Y
    Letter by Wang and Peng Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e27.
    

    >> Share

    
    
51. GUDMUNDSDOTTIR HL, Axelsson Raja A, Rossing K, Rasmusen H, et al
    Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial.
    Circulation. 2025;151:132-144.
    

    >> Share

    
    December 2024
52. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    

    >> Share

    
    November 2024
53. URENA M
    Transseptal Transcatheter Valve-in-Valve Mitral Valve Implantation: Ready for Prime Time.
    Circulation. 2024;150:1505-1507.
    

    >> Share

    
    October 2024
54. RUDOLPH F, Geyer M, Baldus S, De Luca VM, et al
    Transcatheter Repair Versus Surgery for Atrial Versus Ventricular Functional Mitral Regurgitation - a Post-hoc Analysis of the MATTERHORN Trial.
    Circulation. 2024 Oct 30. doi: 10.1161/CIRCULATIONAHA.124.072648.
    

    >> Share

    
    
55. WEDIN JO, Naslund V, Rodin S, Simonson OE, et al
    Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis.
    Circulation. 2024 Oct 23. doi: 10.1161/CIRCULATIONAHA.124.070753.
    

    >> Share

    
    
56. MAURIZI N, Antiochos P, Owens A, Lakdwala N, et al
    Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
    Circulation. 2024;150:1377-1390.
    

    >> Share

    
    
57. BENKHOFF M, Barcik M, Mourikis P, Dahlmanns J, et al
    Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease.
    Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.123.067270.
    

    >> Share

    
    
58. HOEDEMAKERS S, Cosyns B, Droogmans S, Verbrugge FH, et al
    Response by Hoedemakers et al to Letter Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis".
    Circulation. 2024;150:e278-e279.
    

    >> Share

    
    
59. JHA AK
    Letter by Jha Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis".
    Circulation. 2024;150:e276-e277.
    

    >> Share

    
    September 2024
60. SANNINO A, Mahkmudova U
    Artificial Intelligence and Mitral Regurgitation: Friend or Foe?
    Circulation. 2024;150:934-937.
    

    >> Share

    
    
61. 
    Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e267.
    

    >> Share

    
    
62. CRIBIER A, Eltchaninoff H
    Transcatheter Aortic Valve Implantation: Two Decades of a Revolutionary and Ongoing Odyssey.
    Circulation. 2024;150:821-822.
    

    >> Share

    
    
63. RAMO J, Jurgens SJ, Kany S, Choi SH, et al
    Rare Genetic Variants in LDLR, APOB, and PCSK9 are Associated with Aortic Stenosis.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.070982.
    

    >> Share

    
    August 2024
64. SHRIDHAR P, Pal S, Clavere NG, Becker JR, et al
    Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
    Circulation. 2024;150:e201-e202.
    

    >> Share

    
    
65. DAVID TE
    Perspectives on Heart Valve Repair.
    Circulation. 2024;150:661-662.
    

    >> Share

    
    
66. SUN Y, Ren J
    Letter by Sun and Ren Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
    Circulation. 2024;150:e200.
    

    >> Share

    
    
67. VRUDHULA A, Duffy G, Vukadinovic M, Liang D, et al
    High-Throughput Deep Learning Detection of Mitral Regurgitation.
    Circulation. 2024 Aug 12. doi: 10.1161/CIRCULATIONAHA.124.069047.
    

    >> Share

    
    
68. GOEL K, Makkar R, Krishnaswamy A, Kapadia S, et al
    Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States.
    Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.124.068847.
    

    >> Share

    
    July 2024
69. CARRIER L
    RNA Editing Holds Promise for Hypertrophic Cardiomyopathy Therapy.
    Circulation. 2024;150:299-301.
    

    >> Share

    
    
70. YANG P, Lou Y, Geng Z, Guo Z, et al
    Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
    Circulation. 2024;150:283-298.
    

    >> Share

    
    June 2024
71. LONG A, Haggerty CM, Finer J, Hartzel D, et al
    Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR).
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.124.068996.
    

    >> Share

    
    
72. SMALL AM, Yutzey KE, Binstadt BA, Voigts Key K, et al
    Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jun 17. doi: 10.1161/CIR.0000000000001254.
    

    >> Share

    
    
73. QUAST C, Bonner F, Polzin A, Veulemans V, et al
    Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and Systemic Endothelial Dysfunction.
    Circulation. 2024 Jun 5. doi: 10.1161/CIRCULATIONAHA.123.064747.
    

    >> Share

    
    
74. MCGURK KA, Bilgehan N, Ware JS
    Pharmacogenetic Influences Over Mavacamten Pharmacokinetics: Considerations for the Treatment of Individuals With Hypertrophic Cardiomyopathy.
    Circulation. 2024;149:1786-1788.
    

    >> Share

    
    
75. OMMEN SR, Ho CY, Asif IM, Balaji S, et al
    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e1239-e1311.
    

    >> Share

    
    May 2024
76. EVANGELISTA A, Galian-Gay L, Guala A, Teixido-Tura G, et al
    Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.123.067537.
    

    >> Share

    
    
77. KANG DH, Park SJ, Shin SH, Hwang IC, et al
    Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial.
    Circulation. 2024 May 1. doi: 10.1161/CIRCULATIONAHA.124.069144.
    

    >> Share

    
    April 2024
78. SHEN M, Wu JC
    Empowering Valvular Heart Disease Research With Stem Cell-Derived Valve Cells.
    Circulation. 2024;149:1457-1460.
    

    >> Share

    
    
79. DAVIDSON LJ, Tang GHL, Ho EC, Fudim M, et al
    The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 25. doi: 10.1161/CIR.0000000000001232.
    

    >> Share

    
    
80. LI B, Liu F, Chen X, Chen T, et al
    FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System.
    Circulation. 2024;149:1268-1284.
    

    >> Share

    
    February 2024
81. HERRMANN HC, Desai ND
    Incidence, Implications, and Treatment of Patients With Severe Aortic Stenosis and Small Aortic Annulus.
    Circulation. 2024;149:656-657.
    

    >> Share

    
    
82. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    

    >> Share

    
    
83. CRESCI S, Bach RG, Saberi S, Owens AT, et al
    Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
    Circulation. 2024;149:498-509.
    

    >> Share

    
    January 2024
84. HAN D, Zhou T, Li L, Ma Y, et al
    AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease.
    Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.065213.
    

    >> Share

    
    
85. TOPRICEANU CC, Pereira AC, Moon JC, Captur G, et al
    Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
    Circulation. 2024;149:107-123.
    

    >> Share

    
    December 2023
86. SHRIDHAR P, Glennon MS, Pal S, Waldron CJ, et al
    MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1870-1886.
    

    >> Share

    
    November 2023
87. LIN Y, Yang Q, Lin X, Liu X, et al
    Extracellular Matrix Disorganization Caused by ADAMTS16 Deficiency Leads to Bicuspid Aortic Valve With Raphe Formation.
    Circulation. 2023 Nov 29. doi: 10.1161/CIRCULATIONAHA.123.065458.
    

    >> Share

    
    
88. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    

    >> Share

    
    
89. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    

    >> Share

    
    
90. 
    Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023;148:e185.
    

    >> Share

    
    
91. ROGERS MA, Bartoli-Leonard F, Zheng KH, Small AM, et al
    Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.
    Circulation. 2023 Nov 8. doi: 10.1161/CIRCULATIONAHA.123.066822.
    

    >> Share

    
    October 2023
92. RODES-CABAU J, Ribeiro H, Mohammadi S, Serra V, et al
    Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.067326.
    

    >> Share

    
    
93. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    

    >> Share

    
    
94. DAHLE G, Al-Atassi T, Kaneko T
    The Future of Cardiac Surgical Training in the Age of Transcatheter Valvular Interventions.
    Circulation. 2023;148:1295-1297.
    

    >> Share

    
    
95. HARIRI E, Kassis N, Kapadia SR
    Letter by Hariri et al Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".
    Circulation. 2023;148:1267-1268.
    

    >> Share

    
    
96. HASIFIC S, Rasmussen LM, Dahl JS, Diederichsen ACP, et al
    Response by Hasific et al to Letter Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".
    Circulation. 2023;148:1269-1270.
    

    >> Share

    
    September 2023
97. JEX N, Greenwood JP, Cubbon RM, Rider OJ, et al
    Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Circulation. 2023 Sep 25. doi: 10.1161/CIRCULATIONAHA.122.063444.
    

    >> Share

    
    
98. FIGLIOZZI S, Georgiopoulos G, Masci PG
    Letter by Figliozzi et al Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
    Circulation. 2023;148:978-979.
    

    >> Share

    
    
99. ESSAYAGH B, Benfari G, Antoine C, Grigioni F, et al
    Response by Essayagh et al to Letter Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
    Circulation. 2023;148:980-981.
    

    >> Share

    
    
100. AYERS MP, Kramer CM
     Imaging Myofibrillar Disarray and Microvascular Dysfunction in Hypertrophic Cardiomyopathy: Novel Imaging Biomarkers for a New Era in Therapeutics.
     Circulation. 2023;148:819-821.
     

     >> Share

     
     
101. JOY G, Kelly CI, Webber M, Pierce I, et al
     Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
     Circulation. 2023;148:808-818.
     

     >> Share

     
     August 2023
102. REINDL M, Lechner I, Holzknecht M, Tiller C, et al
     Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide Transcatheter Aortic Valve Replacement (TAVR-CMR): A Randomized, Open-Label, Non-Inferiority Trial.
     Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066498.
     

     >> Share

     
     
103. PRAKASH SK, Michelena HI, Milewicz DM
     Bicuspid Aortic Valve and Thoracic Aortic Disease: Further Evidence of Clinically Silent but Deadly Risk to Family Members of Affected Individuals.
     Circulation. 2023;148:648-650.
     

     >> Share

     
     
104. 
     Correction to: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2023;148:e8.
     

     >> Share

     
     
105. ABOU ALAIWI S, Roston TM, Marstrand P, Claggett BL, et al
     Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
     Circulation. 2023;148:394-404.
     

     >> Share

     
     July 2023
106. ARMSTRONG DWJ, Riley LA, Su YR, Shah AS, et al
     Myocardial Neprilysin Is Increased in Hypertrophic Cardiomyopathy.
     Circulation. 2023;148:167-169.
     

     >> Share

     
     
107. BLASER MC, Buffolo F, Halu A, Turner ME, et al
     Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis.
     Circulation. 2023 Jul 10. doi: 10.1161/CIRCULATIONAHA.122.063402.
     

     >> Share

     
     
108. MONDA E, Limongelli G
     Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy".
     Circulation. 2023;148:73.
     

     >> Share

     
     June 2023
109. GLOTZBACH JP, Hanson HA, Tonna JE, Horns JJ, et al
     Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database.
     Circulation. 2023 Jun 15. doi: 10.1161/CIRCULATIONAHA.122.060439.
     

     >> Share

     
     May 2023
110. GALPER BZ, Chinnakondepalli KM, Wang K, Magnuson EA, et al
     Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
     Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.062481.
     

     >> Share

     
     April 2023
111. GOLLMANN-TEPEKOYLU C, Graber M, Hirsch J, Mair S, et al
     Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification.
     Circulation. 2023 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.063481.
     

     >> Share

     
     March 2023
112. RAKOWSKI H, Bataiosu R
     Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost?
     Circulation. 2023;147:864-866.
     

     >> Share

     
     
113. DESAI MY, Owens A, Geske JB, Wolski K, et al
     Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks.
     Circulation. 2023;147:850-863.
     

     >> Share

     
     February 2023
114. TURER AT, Wang A
     Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in Hypertrophic Cardiomyopathy.
     Circulation. 2023;147:700-702.
     

     >> Share

     
     
115. CONWAY J, Min S, Villa C, Weintraub RG, et al
     The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
     Circulation. 2023;147:718-727.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share